These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11220786)

  • 41. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase.
    Chakraborty G; Mekala P; Yahya D; Wu G; Ledeen RW
    J Neurochem; 2001 Aug; 78(4):736-45. PubMed ID: 11520894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspartoacylase supports oxidative energy metabolism during myelination.
    Francis JS; Strande L; Markov V; Leone P
    J Cereb Blood Flow Metab; 2012 Sep; 32(9):1725-36. PubMed ID: 22617649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-acetylaspartate in the vertebrate brain: metabolism and function.
    Baslow MH
    Neurochem Res; 2003 Jun; 28(6):941-53. PubMed ID: 12718449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Eke GH; Iscan A; Cece H; Calik M
    Genet Couns; 2012; 23(1):9-12. PubMed ID: 22611636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes.
    Kolodziejczyk K; Hamilton NB; Wade A; Káradóttir R; Attwell D
    Brain; 2009 Jun; 132(Pt 6):1496-508. PubMed ID: 19383832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Redirecting
    Gessler DJ; Li D; Xu H; Su Q; Sanmiguel J; Tuncer S; Moore C; King J; Matalon R; Gao G
    JCI Insight; 2017 Feb; 2(3):e90807. PubMed ID: 28194442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion.
    Moreno A; Ross BD; Blüml S
    J Neurochem; 2001 Apr; 77(1):347-50. PubMed ID: 11279290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ablating the Transporter Sodium-Dependent Dicarboxylate Transporter 3 Prevents Leukodystrophy in Canavan Disease Mice.
    Wang Y; Hull V; Sternbach S; Popovich B; Burns T; McDonough J; Guo F; Pleasure D
    Ann Neurol; 2021 Nov; 90(5):845-850. PubMed ID: 34498299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of the motor system in two siblings with Canavan's disease: a combined transcranial magnetic stimulation (TMS) - diffusion tensor imaging (DTI) study.
    Kimiskidis VK; Papaliagkas V; Papagiannopoulos S; Zafeiriou D; Kazis D; Tsatsali-Foroglou E; Kouvatsou Z; Kapina V; Koutsonikolas D; Anogianakis G; Geroukis T; Bostantjopoulou S
    Metab Brain Dis; 2017 Apr; 32(2):307-310. PubMed ID: 28130616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel mutation in an Egyptian patient with infantile Canavan disease.
    Zaki OK; El Abd HS; Mohamed SA; Zayed H
    Metab Brain Dis; 2016 Jun; 31(3):573-7. PubMed ID: 26613958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case 15-1998: elevated N-acetylaspartic acid activity in Canavan's disease.
    Breslau J
    N Engl J Med; 1998 Aug; 339(9):636. PubMed ID: 9722443
    [No Abstract]   [Full Text] [Related]  

  • 52. Canavan disease: clinical features and recent advances in research.
    Hoshino H; Kubota M
    Pediatr Int; 2014 Aug; 56(4):477-83. PubMed ID: 24977939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of Canavan disease: the first biochemically proven case in a Japanese girl.
    Hamaguchi H; Nihei K; Nakamoto N; Ezoe T; Naito H; Hara M; Yokota K; Inoue Y; Matsumoto I
    Brain Dev; 1993; 15(5):367-71. PubMed ID: 8279652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-acetyl-aspartate metabolism at the interface of cancer, immunity, and neurodegeneration.
    Krause N; Wegner A
    Curr Opin Biotechnol; 2024 Feb; 85():103051. PubMed ID: 38103520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between enzyme properties and disease progression in Canavan disease.
    Zano S; Wijayasinghe YS; Malik R; Smith J; Viola RE
    J Inherit Metab Dis; 2013 Jan; 36(1):1-6. PubMed ID: 22850825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restricted diffusion in Canavan disease.
    Srikanth SG; Chandrashekar HS; Nagarajan K; Jayakumar PN
    Childs Nerv Syst; 2007 Apr; 23(4):465-8. PubMed ID: 17219235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings.
    Zafeiriou DI; Kleijer WJ; Maroupoulos G; Anastasiou AL; Augoustidou-Savvopoulou P; Papadopoulou F; Kontopoulos EE; Fagan E; Payne S
    Brain Dev; 1999 Apr; 21(3):205-8. PubMed ID: 10372908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational analysis of deleterious missense mutations in aspartoacylase that cause Canavan's disease.
    Sreevishnupriya K; Chandrasekaran P; Senthilkumar A; Sethumadhavan R; Shanthi V; Daisy P; Nisha J; Ramanathan K; Rajasekaran R
    Sci China Life Sci; 2012 Dec; 55(12):1109-19. PubMed ID: 23233226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early diagnosis of Canavan syndrome: how can we get there?
    De Bernardo G; Giordano M; Sordino D; Buono S
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26245283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A case of Canavan-Van Bogaert-Bertrand leukodystrophy].
    Mikhaĭlova SV; Zakharova EIu; Bukina AM; Il'ina ES; Pokrovskaia AIa; Fedoniuk ID; Bembeeva RTs; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):50-4. PubMed ID: 15270300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.